|Day Low/High||211.79 / 213.36|
|52 Wk Low/High||166.88 / 213.36|
Stock futures move lower in a retreat from a rally a day earlier as Senate Republicans struggle to get their tax bill over the finish line.
CVS is expected to pay more than $66 billion for the health care company
U.S. stock futures are pointing to losses for Wall Street on Friday, after the Senate delays a vote on its tax reform bill over deficit concerns.
The Dow climbed more than 300 points Thursday.
The drugstore chain's deal for the insurer, which could be valued at more than $70 billion, would affect healthcare much more than retail.
The Dow Jones Industrial Average has crossed the 24,000 threshold.
Here's what you need to know for Tuesday, Nov. 21
CVS is showing red flags as investors mull Aetna acquisition.
The pharmacy chain could arrive at a deal to acquire the health insurer for more than $66 billion by the end of the month.
Jim Cramer is bullish on McDonald's, Ultra Clean Holdings, Aetna, Baozun and more.
Jim Cramer analyzes the reasons investors should be worried, and more important, why this is the pullback that presents buying opportunities.
More than one in five who signed up for Obamacare open enrollment during its first week were new customers.
Mergers reducing an industry's size to four players from five will be OK, while deals involving Chinese buyers face long odds. The jury is still out on vertically integrated deals.
Aetna (NYSE: AET) announced the launch of Aetna Medicare Rx® Select (PDP).
Former Apple CEO John Sculley has made various bets since he left the tech giants years ago. One more recent bet is on healthcare via digitally-minded PBM RxAdvance.
The drugstore beat Wall Street estimates in Q3 earnings
A deal with Rite Aid that hasn't performed and pressures from Amazon and CVS are continuing to mount.
The pharmacy chain and health insurer are working on sealing a deal north of $70 billion as early as December, Reuters reported.
Another rally in the tech sector gives the Nasdaq the energy to close out October with another record on Tuesday.
On the heels of a WSJ report on deal discussions between CVS Health and Aetna, executives at Aetna said on an earnings call Tuesday they are not commenting on rumors.
Stocks are slightly higher as tech gains kept the Nasdaq in the green.
Stocks are mixed as a surprise selloff in Pfizer shares weigh on the Dow Jones Industrial Average but tech gains keep the Nasdaq in the green.
Stock futures move higher on Tuesday, setting up for a recovery from losses a day earlier as U.S. central bankers convene for a policy meeting.
The fundamentals are there, supported by earnings. Let's look at the charts.
U.S. stock futures are rising on Tuesday, as the Federal Reserve begins a two-day policy meeting.
Aetna (NYSE: AET) announced third-quarter 2017 net income (1) of $838 million, or $2.
Despite the fundamental efficiencies of the deal, for CVS, the technical picture looks pretty bad.
Approximately 60 percent of a person's life expectancy is driven by factors outside of the doctor's office - our individual behaviors, as well as social and environmental factors 1.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.